Reporting owner · Q3 2026 · CIK 1213307

Welters Anthony: insider trades.

Welters Anthony reported 6 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($2.7M), across 1 company.

Transactions
6
Purchases (P)
0
Sales (S)
4
Companies
1
Name as filed
WELTERS ANTHONY

Companies

CompanyRelationshipTransactions
Gilead Sciences, Inc. (GILD)Director6

Transactions

6 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-08-26Gilead Sciences, Inc.S4,600$148.8212,894Form 4
2026-08-26Gilead Sciences, Inc.S6,880$148.8212,894Form 4
2026-08-26Gilead Sciences, Inc.S3,402$148.2419,774Form 4
2026-08-26Gilead Sciences, Inc.S3,118$148.3117,494Form 4
2026-08-26Gilead Sciences, Inc.M10,282$61.3523,176Form 4
2026-08-26Gilead Sciences, Inc.M7,718$60.6720,612Form 4

Questions

What stock did Welters Anthony buy or sell?

Welters Anthony reported 6 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($2.7M), across 1 company.

Is Welters Anthony the same person as other filers with this name?

This page covers SEC CIK 1213307 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/welters-anthony-1213307.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.